NUDT15 intermediate metabolisers are associated with lower loss of response in paediatric Crohn’s disease patients treated by combination treatment with infliximab and azathioprine
Keyword(s):
2016 ◽
Vol 10
(7)
◽
pp. 795-804
◽
Keyword(s):
2012 ◽
Vol 51
(6)
◽
pp. 595-599
◽
2016 ◽
Vol 10
(10)
◽
pp. 1237-1244
◽
Keyword(s):
2011 ◽
Vol 33
(9)
◽
pp. 987-995
◽
2018 ◽
Vol 88
(2)
◽
pp. 89-99
◽
Keyword(s):
2015 ◽
Vol 47
(8)
◽
pp. 658-662
◽
Keyword(s):